APA (7th ed.) Citation

RS, R., MH, D., NA, L., J, B., & R, P. (2015). Underappreciated opportunities for high-density lipoprotein particles in risk stratification and potential targets of therapy. Cardiovascular drugs and therapy, 29(1), 41. https://doi.org/10.1007/s10557-014-6567-0

Chicago Style (17th ed.) Citation

RS, Rosenson, Davidson MH, Le NA, Burkle J, and Pourfarzib R. "Underappreciated Opportunities for High-density Lipoprotein Particles in Risk Stratification and Potential Targets of Therapy." Cardiovascular Drugs and Therapy 29, no. 1 (2015): 41. https://doi.org/10.1007/s10557-014-6567-0.

MLA (9th ed.) Citation

RS, Rosenson, et al. "Underappreciated Opportunities for High-density Lipoprotein Particles in Risk Stratification and Potential Targets of Therapy." Cardiovascular Drugs and Therapy, vol. 29, no. 1, 2015, p. 41, https://doi.org/10.1007/s10557-014-6567-0.